GOLDMAN SACHS GROUP INC - VIVEVE MED INC ownership

VIVEVE MED INC's ticker is VIVE and the CUSIP is 92852W204. A total of 19 filers reported holding VIVEVE MED INC in Q3 2016. The put-call ratio across all filers is - and the average weighting 1.1%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of VIVEVE MED INC
ValueSharesWeighting
Q3 2018$99,000
-51.0%
36,922
-50.2%
0.00%
Q2 2018$202,000
+140.5%
74,169
+223.2%
0.00%
Q1 2018$84,000
-16.0%
22,947
+13.7%
0.00%
Q4 2017$100,000
-21.9%
20,189
-17.3%
0.00%
Q3 2017$128,000
-17.4%
24,417
-0.1%
0.00%
Q1 2017$155,000
+4.0%
24,453
-15.6%
0.00%
Q4 2016$149,000
-45.0%
28,967
-22.8%
0.00%
Q3 2016$271,00037,5120.00%
Other shareholders
VIVEVE MED INC shareholders Q3 2016
NameSharesValueWeighting ↓
Stonepine Capital Management, LLC 3,403,402$1,293,0000.89%
RTW INVESTMENTS, LP 4,480,565$1,703,0000.09%
Nantahala Capital Management 6,581,465$2,501,0000.08%
MEITAV INVESTMENT HOUSE LTD 917,973$352,0000.02%
J. Goldman & Co LP 305,556$116,0000.01%
Cedar Brook Financial Partners, LLC 40,000$15,0000.01%
KNOTT DAVID M 43,649$17,0000.01%
HighTower Advisors, LLC 1,920,551$728,0000.00%
Sargent Investment Group, LLC 10,000$4,0000.00%
BOOTHBAY FUND MANAGEMENT, LLC 31,573$12,0000.00%
View complete list of VIVEVE MED INC shareholders